50
Participants
Start Date
June 28, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
NCC-Sp Assay
Orphalan has developed a new NCC speciation assay (NCC-Sp) using liquid chromatography inductively coupled plasma mass spectroscopy (LC-ICP-MS) to measure serum copper and ceruloplasmin bound copper from which non ceruloplasmin bound copper (NCC) is estimated.
New York Presbyterian Hospital-Columbia University Medical Centre, New York
John Hopkins Hospital, Baltimore
Advent Health Orlando, Orlando
University of Miami, Miami
Vanderbilt University Medical Centre, Nashville
University of Michigan, Ann Arbor
Northwestern University Chicago (Hepatologist), Chicago
UC Davis Midtown Ambulatory Care Centre, Sacramento
Yale University School of Medicine, New Haven
Lead Sponsor
Orphalan
INDUSTRY